钆类造影剂的研究进展
|
|
段二月,马建功,程鹏
|
Advances in Gadolinium(Ⅲ) Chelates as MRI Contrast Agents
|
|
Er-Yue DUAN,Jian-Gong MA,Peng CHENG
|
|
| 表1 临床应用的Gd-DTPA类造影剂的商用名称、配体结构、相对分子质量和弛豫效率 |
| |
|
| 造影剂名称 | 商用名称 | 配体结构 | Mw/(g·mol-1) | r1/(L·mmol-1·s-1) | ![]() | | Gd-DTPA | Magnevist | R1=OH;R2=R3=H | 547 | 3.8 | | Gd-DTPA-BMA | Omniscan | R1=NHCH3;R2=R3=H | 573 | 3.8 | | Gd-DTPA-BMEA | OptiMARK | R1=NH(CH2)OCH3;R2=R3=H | 661 | 4.1 | | Gd-BOTPA | MultiHance | R1=OH;R2=H;R3=CH2OCH2C6H5 | 711 | 4.8 | | Gd-EOB-DTPA | Primovist | R1=OH;R2=C6H5OCH2CH3;R3=H | 682 | 5.5 |
|
|
|